Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-12-17
1994-02-08
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4316, A61K 3135
Patent
active
052848698
ABSTRACT:
The occurence of restenosis following percutaneous transluminal coronary angioplasty is prevented or inhibited using a photopheresis treatment method. In accordance with the photopheresis treatment method, a photoactive compound such as 8-methoxypsoralen is administered to the patient's blood or affected tissue, or some fraction thereof, in vitro or in vivo using conventional administration routes. A portion of the patient's blood or affected tissue is then treated (preferably, extracorporeally) using photopheresis, which comprises subjecting the blood or affected tissue to electromagnetic radiation in a wavelength suitable for activating the photoactive compound, such as ultraviolet light, preferably long wavelength ultraviolet light in the wavelength range of 320 to 400 nm, commonly called UVA light. The treated blood or affected tissue, or a fraction thereof, is returned to the patient (in the case of extracoporeal photopheresis) or remains in the patient (following in vivo photopheresis).
REFERENCES:
patent: 4321919 (1982-03-01), Edelson
patent: 4683889 (1987-08-01), Edelson
patent: 5116864 (1992-05-01), March et al.
Bisaccia Emil
Klainer Albert S.
Nutter Nathan M.
Waddell Mark E.
LandOfFree
Photophoresis methods for treating atherosclerosis and for preve does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Photophoresis methods for treating atherosclerosis and for preve, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Photophoresis methods for treating atherosclerosis and for preve will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-698245